Cibc World Markets Corp Viridian Therapeutics, Inc.\De Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Cibc World Markets Corp holds 16,557 shares of VRDN stock, worth $271,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,557Holding current value
$271,700% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VRDN
# of Institutions
189Shares Held
79.7MCall Options Held
92.2KPut Options Held
55.2K-
Deep Track Capital, LP Greenwich, CT5.38MShares$88.3 Million2.54% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$78.3 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.7MShares$77.1 Million5.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.51MShares$74 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$63.7 Million12.64% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $655M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...